SNZZF (Senzime AB) E10: $-0.12 (As of Mar. 2026)


SNZZF Senzime AB SNZZF
68 GF Score
Price $0.48
GF Value $1.21
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Senzime AB E10?

Senzime AB SNZZF 68 E10 is $-0.12 as of Mar. 2026. GuruFocus rates SNZZF with a GF Score™ of 68/100 and a GF Value™ of $1.21 (Possible Value Trap). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Senzime AB's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.015. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.12 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Senzime AB was -6.00% per year. The lowest was -16.00% per year. And the median was -11.00% per year.

As of today (2026-06-27), Senzime AB's current stock price is $0.47855. Senzime AB's E10 for the quarter that ended in Mar. 2026 was $-0.12. Senzime AB's Shiller PE Ratio of today is .


Senzime AB  (OTCPK:SNZZF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Senzime AB E10 Related Terms


Senzime AB E10 Historical Data

* Premium members only.

The historical data trend for Senzime AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senzime AB E10 Chart

Senzime AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.08 -0.10 -0.10 -0.11

Senzime AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.11 -0.12 -0.11 -0.12

SNZZF vs ABT, SYK, MDT: E10 Comparison

For the Medical Devices subindustry, Senzime AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senzime AB Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Senzime AB's Shiller PE Ratio falls into.


SNZZF
68GF Score
Senzime AB SNZZF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senzime AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Senzime AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.015/133.3862*133.3862
=-0.015

Current CPI (Mar. 2026) = 133.3862.

Senzime AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.011 101.019 -0.015
201609 -0.007 101.138 -0.009
201612 -0.011 102.022 -0.014
201703 -0.012 102.022 -0.016
201706 -0.008 102.752 -0.010
201709 -0.007 103.279 -0.009
201712 -0.011 103.793 -0.014
201803 -0.012 103.962 -0.015
201806 -0.013 104.875 -0.017
201809 -0.013 105.679 -0.016
201812 -0.023 105.912 -0.029
201903 -0.019 105.886 -0.024
201906 -0.018 106.742 -0.022
201909 -0.014 107.214 -0.017
201912 -0.018 107.766 -0.022
202003 -0.016 106.563 -0.020
202006 -0.023 107.498 -0.029
202009 -0.022 107.635 -0.027
202012 -0.031 108.296 -0.038
202103 -0.031 108.360 -0.038
202106 -0.041 108.928 -0.050
202109 -0.035 110.338 -0.042
202112 -0.041 112.486 -0.049
202203 -0.034 114.825 -0.039
202206 -0.062 118.384 -0.070
202209 -0.037 122.296 -0.040
202212 -0.062 126.365 -0.065
202303 -0.040 127.042 -0.042
202306 -0.039 129.407 -0.040
202309 -0.030 130.224 -0.031
202312 -0.032 131.912 -0.032
202403 -0.022 132.205 -0.022
202406 -0.027 132.716 -0.027
202409 -0.025 132.304 -0.025
202412 -0.018 132.987 -0.018
202503 -0.027 132.825 -0.027
202506 -0.025 133.699 -0.025
202509 -0.017 133.482 -0.017
202512 -0.029 133.386 -0.029
202603 -0.015 133.386 -0.015

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.12 mean?
Senzime AB (SNZZF) has a E10 of $-0.12 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Senzime AB and its competitors.
Is Senzime AB's E10 too high?
Senzime AB's current E10 is $-0.12. Overall, Senzime AB has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senzime AB's E10 compare to ABT and SYK?
Senzime AB's E10 of $-0.12 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Senzime AB and its competitors. Senzime AB's current E10 is $-0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senzime AB stock overvalued right now?
Based on GuruFocus' analysis, Senzime AB (SNZZF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.21, compared to a current price of $0.48 — trading 60.5% below its estimated fair value. The current E10 is $-0.12. Senzime AB's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Senzime AB (SNZZF), the current E10 is $-0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Senzime AB (SNZZF) Overvalued in 2026?

Based on GuruFocus' analysis, Senzime AB stock appears to be undervalued. The current stock price of $0.48 is trading 60.5% below its estimated GF Value™ of $1.21. GuruFocus considers Senzime AB to be Possible Value Trap.

Key valuation signals for SNZZF:

  • E10: $-0.12
  • GF Value™: $1.21 vs. price of $0.48 (60.5% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the SNZZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Senzime AB Business Description

Other Exchanges SEZI:Sweden6YC:Germany
Address Verkstadsgatan 8, hus 1, Uppsala, SWE, 753 23
Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.
68GF Score

Get the complete analysis for SNZZF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.48
Price
$1.21
GF Value